Related Experiment Video
Updated: Nov 26, 2025

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Antioxidants Targeting Mitochondrial Oxidative Stress: Promising Neuroprotectants for Epilepsy
Nan Yang1,2,3,4, Qi-Wen Guan1,2,3,4, Fang-Hui Chen5
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, China.
Abstract:
Mitochondria are major sources of reactive oxygen species (ROS) within the cell and are especially vulnerable to oxidative stress. Oxidative damage to mitochondria results in disrupted mitochondrial function and cell death signaling, finally triggering diverse pathologies such as epilepsy, a common neurological disease characterized with aberrant electrical brain activity. Antioxidants are considered as promising neuroprotective strategies for epileptic condition via combating the deleterious effects of excessive ROS production in mitochondria. In this review, we provide a brief discussion of the role of mitochondrial oxidative stress in the pathophysiology of epilepsy and evidences that support neuroprotective roles of antioxidants targeting mitochondrial oxidative stress including mitochondria-targeted antioxidants, polyphenols, vitamins, thiols, and nuclear factor E2-related factor 2 (Nrf2) activators in epilepsy. We point out these antioxidative compounds as effectively protective approaches for improving prognosis. In addition, we specially propose that these antioxidants exert neuroprotection against epileptic impairment possibly by modulating cell death interactions, notably autophagy-apoptosis, and autophagy-ferroptosis crosstalk.
Insights
Mitochondrial oxidative stress contributes to epilepsy. Antioxidants targeting mitochondria show neuroprotective effects by modulating cell death pathways, offering hope for improved epilepsy prognosis.
Area of Science:
- Biochemistry
- Neuroscience
- Cell Biology
Background:
- Mitochondria generate reactive oxygen species (ROS), making them susceptible to oxidative stress.
- Mitochondrial damage contributes to cell death and neurological disorders like epilepsy.
- Excessive ROS in epilepsy pathophysiology highlights the need for antioxidant interventions.
Purpose of the Study:
- To review the role of mitochondrial oxidative stress in epilepsy.
- To discuss the neuroprotective potential of various antioxidants targeting mitochondria in epilepsy.
- To explore the mechanisms of antioxidant action, including modulation of cell death pathways.
Main Methods:
- Literature review on mitochondrial oxidative stress and epilepsy.
- Analysis of studies on antioxidant efficacy in epilepsy models.
- Examination of evidence for antioxidant modulation of autophagy, apoptosis, and ferroptosis.
Main Results:
- Mitochondrial oxidative stress is implicated in epilepsy development and progression.
- Targeted antioxidants, including mitochondria-specific agents, polyphenols, vitamins, thiols, and Nrf2 activators, demonstrate neuroprotective effects.
- Antioxidants may exert neuroprotection by influencing interactions between autophagy, apoptosis, and ferroptosis.
Conclusions:
- Antioxidants targeting mitochondrial oxidative stress are promising for epilepsy treatment.
- Modulating cell death pathways like autophagy-apoptosis and autophagy-ferroptosis is a key mechanism for antioxidant neuroprotection in epilepsy.
- Further research into these mechanisms can optimize antioxidant therapies for epilepsy.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

